Akari Therapeutics (AKTX)
1.18
0.03 (2.61%)
At close: Jan 15, 2025, 10:58 AM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 |
| Net Income | -10.01M | -17.75M | -17.42M | -20.45M | -24.75M | -23.50M | -35.40M | -18.14M | -45.32M | -9.65M | -3.62M | -4.27M | -2.12M | -675.00K |
| Depreciation & Amortization | 4.00K | 3.71K | 4.13K | 8.00K | 18.00K | 39.00K | 42.40K | 39.94K | 10.16K | 8.00K | 2.00K | 2.00K | n/a | n/a |
| Stock-Based Compensation | 1.15M | 735.00K | 314.65K | 325.52K | 1.05M | 1.65M | 2.73M | 3.93M | 1.79M | 468.00K | 94.00K | 514.00K | 140.00K | n/a |
| Other Working Capital | 70.00K | -877.11K | -1.74M | -2.91M | 5.89M | 3.07M | 799.05K | -778.59K | -3.75B | 33.00K | -434.00K | 1.40M | 475.00K | 181.00K |
| Other Non-Cash Items | -7.65M | -5.32M | 242.50K | 3.22M | 169.00K | -105.00K | 2.70M | -9.01M | 45.29M | -552.00K | -286.00K | -418.00K | -120.00K | -95.00K |
| Deferred Income Tax | n/a | n/a | n/a | 2.86M | 2.99M | n/a | -2.49M | -3 | -11.41M | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | 70.00K | 821.89K | -1.98M | -2.91M | 8.27M | -619.00K | 811.27K | -1.45M | 4.67M | 263.00K | -1.64M | 2.04M | 1.09M | 404.00K |
| Operating Cash Flow | -16.43M | -21.50M | -18.85M | -16.95M | -12.26M | -22.54M | -31.60M | -24.62M | -4.97M | -9.46M | -5.45M | -2.13M | -1.01M | -366.00K |
| Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | -36.88K | -54.75K | -10.56K | -57.00K | n/a | 4.00K | n/a | n/a |
| Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.41M | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -46.12M | n/a | -142.00K | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | 10.02M | 36.10M | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | 10.02K | 10.08K | -8.22K | -142.00K | n/a | n/a | n/a | n/a |
| Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | 9.99M | -10.07M | 1.39M | -199.00K | n/a | 4.00K | n/a | n/a |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 432.35K | -1.10M | 890.00K | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 7.02M | 94.00K | n/a | 27.50K | n/a | -194.00K | n/a | n/a | -5.96M | 4.10M | n/a | n/a | n/a | n/a |
| Financial Cash Flow | 7.02M | 25.29M | 14.29M | 25.07M | 11.99M | 306.00K | 15.67M | n/a | 69.04M | 8.22M | 12.00M | 3.23M | 1.00M | 372.00K |
| Net Cash Flow | -9.40M | 3.89M | -4.69M | 8.32M | -236.00K | -22.28M | -5.99M | -34.82M | 65.59M | -1.44M | 6.55M | 1.10M | -3.00K | 6.00K |
| Free Cash Flow | -16.43M | -21.50M | -18.85M | -16.95M | -12.26M | -22.54M | -31.64M | -24.68M | -4.98M | -9.52M | -5.45M | -2.13M | -1.01M | -366.00K |